Literature DB >> 27075321

Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.

Seo Ki Kim1, Inhye Park1, Jung-Woo Woo2, Jun Ho Lee3, Jun-Ho Choe1, Jung-Han Kim1, Jee Soo Kim4.   

Abstract

BACKGROUND: Because lymph node (LN) metastasis has been proven to be a predictor for locoregional recurrence (LRR) in papillary thyroid microcarcinoma (PTMC), better knowledge about the predictors for LN metastasis in PTMC is required.
METHODS: We retrospectively reviewed 5656 PTMC patients who underwent total thyroidectomy and central neck dissection and/or lateral neck dissection between January 1997 and June 2015.
RESULTS: Male gender (adjusted odds ratio [OR] 2.332), conventional variant (adjusted OR 4.266), tumor size >0.5 cm (adjusted OR 1.753), multiplicity (adjusted OR 1.168), bilaterality (adjusted OR 1.177), and extrathyroidal extension (ETE) (adjusted OR 1.448) were independent predictors for high prevalence of central LN metastasis (CLNM), whereas per 10-year age increment (adjusted OR 0.760) and chronic lymphocytic thyroiditis (adjusted OR 0.791) were independent predictors for low prevalence of CLNM. In addition, male gender (adjusted OR 1.489), tumor size >0.5 cm (adjusted OR 1.295), multiplicity (adjusted OR 1.801), ETE (adjusted OR 1.659), and CLNM (adjusted OR 4.359) were independent predictors for high prevalence of lateral LN metastasis (LLNM), whereas per 10-year age increment (adjusted OR 0.838) was an independent predictor for low prevalence of LLNM. There was a statistically significant difference in LRR with regard to nodal stage (p < 0.001).
CONCLUSIONS: Meticulous perioperative evaluation of LN metastasis is required for PTMC patients with the above predictors.

Entities:  

Mesh:

Year:  2016        PMID: 27075321     DOI: 10.1245/s10434-016-5225-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  33 in total

1.  Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.

Authors:  X Wei; Y Min; Y Feng; D He; X Zeng; Y Huang; S Fan; H Chen; J Chen; K Xiang; H Luo; G Yin; D Hu
Journal:  J Endocrinol Invest       Date:  2021-09-07       Impact factor: 4.256

2.  Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.

Authors:  Wen-Qing Liu; Jing-Yi Yang; Xiao-Hui Wang; Wei Cai; Fei Li
Journal:  BMC Surg       Date:  2022-06-15       Impact factor: 2.030

3.  Can Cervical Lymph Node Metastasis Increase the Risk of Distant Metastasis in Papillary Thyroid Carcinoma?

Authors:  Wenlong Wang; Ying Ding; Wei Jiang; Xinying Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

4.  Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.

Authors:  Hu Hei; Yanqing Li; Ziyu Luo; Xiaofei Chai; He Zhang; Chen Zheng; Bin Zhou; Wenbo Gong; Jianwu Qin
Journal:  Langenbecks Arch Surg       Date:  2022-02-10       Impact factor: 2.895

Review 5.  The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.

Authors:  Roberto Vita; Antonio Ieni; Giovanni Tuccari; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

6.  Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.

Authors:  Xingjie Yin; Chunping Liu; Yawen Guo; Xiaoyu Li; Na Shen; Xiangwang Zhao; Pan Yu; Shan Wang; Zeming Liu
Journal:  World J Surg Oncol       Date:  2017-07-17       Impact factor: 2.754

7.  Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma.

Authors:  Muye Song; Ziyang Huang; Shujie Wang; Jianhao Huang; Hongyan Shi; Yongchen Liu; Yijie Huang; Ying Yin; Zeyu Wu
Journal:  Gland Surg       Date:  2020-08

8.  Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients.

Authors:  Kai Qian; Kai Guo; Xiaoke Zheng; Tuanqi Sun; Duanshu Li; Yi Wu; Qinghai Ji; Zhuoying Wang
Journal:  Oncotarget       Date:  2017-07-22

9.  CUNR scoring system for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma.

Authors:  Jianyong Lei; Gengpeng Li; Zhihui Li; R X Rong; Jingqiang Zhu
Journal:  Oncotarget       Date:  2017-11-30

10.  INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression.

Authors:  Hongyu Guan; Yan Guo; Liehua Liu; Runyi Ye; Weiwei Liang; Hai Li; Haipeng Xiao; Yanbing Li
Journal:  Cell Biosci       Date:  2018-04-05       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.